Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Mild Traumatic Brain Injury - Mark A. Mentzer

Mild Traumatic Brain Injury

A Science and Engineering Perspective

(Autor)

Buch | Softcover
132 Seiten
2023
CRC Press (Verlag)
978-0-367-56776-7 (ISBN)
CHF 79,95 inkl. MwSt
Mild traumatic brain injury, also known as chronic traumatic encephalopathy, presents a crisis in contact sports, the military, and elsewhere. This book reviews current understanding of mTBI, methods of diagnosis, treatment, policy concerns, and emerging technologies.
Mild traumatic brain injury (mTBI), directly related to chronic traumatic encephalopathy, presents a crisis in contact sports, the military, and public health. Mild Traumatic Brain Injury: A Science and Engineering Perspective reviews current understanding of mTBI, methods of diagnosis, treatment, policy concerns, and emerging technologies. It details the neurophysiology and epidemiology of brain injuries by presenting disease models and descriptions of nucleating events, characterizes sensors, imagers, and related diagnostic measures used for evaluating and identifying brain injuries, and relates emerging bioinformatics analysis with mTBI markers. The book goes on to discuss issues with sports medicine and military issues; covers therapeutic strategies, surgeries, and future developments; and finally addresses drug trials and candidates for therapy. The broad coverage and accessible discussions will appeal to professionals in diverse fields related to mTBI, students of neurology, medicine, and biology, as well as policy makers and lay persons interested in this hot topic.

Features






Summarizes the entire scope of the field of mTBI



Details the neurophysiology, epidemiology, and presents disease models and descriptions of nucleating events



Characterizes sensors, imagers, and related diagnostic measures and relates emerging bioinformatics analysis with mTBI markers



Discusses issues with sports medicine and military issues



Covers therapeutic strategies, surgeries, and future developments and addresses drug trials and candidates

Dr Mark Mentzer earned his PhD in Electrical Engineering from the University of Delaware. He is a former research scientist at the US Army Research Laboratory where he studied mild traumatic brain injury and developed early-detection brain injury helmet sensors. He is a certified test director and contracting officer representative. He possesses two Level-III Defense Acquisition University Certifications in Science and Technology Management and in Test and Evaluation. During his career, he developed a wide range of sensors and instrumentation as well as biochemical processes to assess brain trauma. Mentzer currently teaches graduate systems engineering and computer science courses at the University of Maryland University College.

Dr. Mark Mentzer received his PhD in Electrical Engineering from thr University of Delaware. He is a former research scientist at the US Army Research Laboratory where he studied mild traumatic brain injury and developed early-detection brain injury helmet sensors. He is a certified test director and contracting officer representative. He possesses two Level-III Defense Acquisition University Certifications in Science and Technology Manager and in Test and Evaluation. During his career, he developed a wide range of sensors and instrumentation as well as biochemical processes to assess brain trauma. Mentzer currently teaches high school mathematics and physics at the Salisbury School, college math at the Virginia Eastern Shore Community College, and online graduate systems engineering and computer science courses for University of Maryland University College.

1. Clinical Sequelae and Functional Outcomes. 2 Diagnosing mTBI. 3. Instrumentation for Assessing mTBI events. 4. mTBI in the Military and Contact Sports. 5. Therapeutic Strategies and Future Research. Appendix 1. US Patent 9,080,984 Blast, Ballistic and Blunt Trauma Sensor. Appendix 2. Significance of the NMDA Cell Surface Receptor. Appendix 3. Neuroproteomics, Protein Folding, Transcription Factors, and Epigenetics for TBI Research. Appendix 4. Rhodopsin and Signal Transduction.

Erscheinungsdatum
Verlagsort London
Sprache englisch
Maße 156 x 234 mm
Gewicht 453 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Neurologie
Medizin / Pharmazie Physiotherapie / Ergotherapie Orthopädie
Naturwissenschaften Biologie Humanbiologie
Naturwissenschaften Biologie Zoologie
Technik Medizintechnik
Technik Umwelttechnik / Biotechnologie
ISBN-10 0-367-56776-8 / 0367567768
ISBN-13 978-0-367-56776-7 / 9780367567767
Zustand Neuware
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
interdisziplinäre Diagnose- und Behandlungsstrategien

von Christoph Maier; Ulrike Bingel; Esther Pogatzki-Zahn

Buch | Hardcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 135,75